Bárbara Silva1, Carla Fernandes2, Maria Elizabeth Tiritan3, Madalena M M Pinto2, Maria João Valente4, Márcia Carvalho5, Paula Guedes de Pinho4, Fernando Remião4. 1. UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal ; Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal. 2. Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal ; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal. 3. Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal ; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal ; Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde (IINFACTS), CESPU, Rua Central de Gandra, 1317, 4585-116 Gandra PRD, Portugal. 4. UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. 5. UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal ; FP-ENAS, CEBIMED, Fundação Ensino e Cultura Fernando Pessoa, Universidade Fernando Pessoa, Praça de 9 de Abril, 349, 4249-004 Porto, Portugal.
Abstract
Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in "legal highs" acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized "legal highs" in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylose tris-3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S-(-)-MDPV and R-(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model.
Recently, great interest has been focused on synthetic cathinones since their consumption has increased exponentially. All synthetic cathinones exist as chiral molecules; the biological and/or toxicological properties of cathinones generally differ according to the enantiomers in human body. In this study, a chiral liquid chromatography method was developed to separate and determine the enantiomeric ratio of synthetic cathinones present in "legal highs" acquired in old smart shops or over the Internet. All the synthetic cathinones were efficiently enantio-separated with α and Rs ranging from 1.24 to 3.62 and from 1.24 to 10.52, respectively, using polysaccharide-based chiral stationary phases. All synthetic cathinones, with the exception of 4-methylethcathinone (4-MEC), were present in the commercialized "legal highs" in an enantiomeric proportion of 50:50. One of the studied chiral compounds was 3,4-methylenedioxypyrovalerone (MDPV), one of the most consumed cathinone derivative worldwide. Our research group has recently reported its hepatotoxicity in the racemic form. Thus, the analytical enantioresolution of the MDPV was scaled up to multi-milligram using a semi-preparative amylosetris-3,5-dimethylphenylcarbamate column (20 cm × 7.0 mm ID, 7 µm particle size). Both enantiomers were isolated with high enantiomeric purity (enantiomeric excess > 99 %). The toxicity of S-(-)-MDPV and R-(+)-MDPV was evaluated, for the first time, using primary cultures of rat hepatocytes. It was also possible to verify that MDPV enantiomers showed hepatotoxicity in a concentration-dependent manner, but displayed no enantioselective toxicity in this cell culture model.
Entities:
Keywords:
Cytotoxicity according to enantiomers; Enantioresolution; MDPV enantiomer; Synthetic cathinones; “Legal highs”
In the early twenty-first century, the “legal highs” market was
started [1]. The speed of emergence and
effectiveness of these new psychotropic drugs appearing in the market via “smart
shops” or the Internet, circumventing the implemented laws in many countries around
the world, have generated a huge concern in the legislation and scientific community
[2]. The most common constituents of
the “legal highs” are analogs of the natural cathinone, found in the plant Catha edulis (Khat), and are obtained by synthesis
[3]. This trend has been demonstrated
to be true considering that only during 2014, in a total of 101 new psychoactive
substances, 31 were synthetic cathinones [4]. Currently, there are no commercial devices for the routine
screening of these compounds [5].
Cathinone’s chronic abuse may result in adverse effects such as anxiety,
hallucinations, paranoid agitation, hypertension, delusions, hyperreflexia, and
tachycardia, and may eventually lead to acute liver and/or kidney failure and
rhabdomyolysis [3]. Moreover, the
synthetic cathinones have been involved in an increased number of fatalities
[6]. Because of this and the fact that
new cathinones continue to be consumed and synthesized [7-9],
the study of these compounds is of enormous interest, as they are potentially
dangerous to consumers’ health.Cathinone and all derivatives are chiral and, as a consequence, their
biological and toxicological activities can differ for each of the enantiomers.
Actually, it is well known that in a chiral environment such as the human body, the
enantiomers may have different biological activities and different intensity of
action; sometimes the effect can be limited to only one enantiomer with another
often responsible for side effects or even high toxicity [10]. Literature concerning information of the
isolated enantiomers of synthetic cathinones is scarce. Nevertheless, the evidence
of enantioselectivity was demonstrated with higher stimulating effects of the
S-(−) enantiomer of methcathinone when compared
to the R-(+) enantiomer [11-13]. Moreover, Greg et al. [14] studied the mephedrone enantioselectivity and discovered that
R-mephedrone was much less potent than
S-mephedrone as a substrate at
5-hydroxytryptamine transporters. Gannon et al. [15] showed recently that the S-3,4-methylenedioxypyrovalerone (S-MDPV) enantiomer is likely responsible for the majority of biologic
effects of racemate. Thus, the development of analytical and semi-preparative
enantioresolution methods is crucial to further toxicological studies of both
enantiomers.Considering analytical application, several techniques related to the
enantiomeric resolution of synthetic cathinones were described, including capillary
electrophoresis [16-20], gas chromatography [21-25], liquid chromatography (LC) [25-30], and capillary
electrochromatography [31]. Among all
of these works, there are only three reports related to the enantiomeric separation
of synthetic cathinones by LC using chiral stationary phases (CSPs): Mohr et al.
[26] described the separation of the
enantiomers of 19 derivatives of cathinones with the
Chiralpak® AS-H column; the enantiomers of
methcathinone and cathinone were separated by Perera et al. [27] using the (S,S)-Whelk-O® 1, and Wolrab et al.
[30] described the enantioseparation
of cathinone derivatives using chiral ion-exchange type stationary phases.Regarding preparative resolution by LC, the enantiomers of MDPV were
separated after derivatization [28]. To
our knowledge, this is the first report regarding the preparative enantioresolution
of cathinones by using CSPs.Recently, in our group, 27 samples of “legal highs”, obtained in the
old “smart shops”, were analyzed by gas chromatography–mass spectroscopy (GC–MS) and
nuclear magnetic resonance (NMR) spectroscopy, and concluded that the majority of
the compounds present in these samples were synthetic cathinones [32]. The in vitro hepatotoxic effects of
individual synthetic cathinones were evaluated, and pentedrone and MDPV proved to be
the most potent with EC50 values of 0.664 and 0.742 mM,
respectively, which are similar to that of methylenedioxyamphetamine (MDMA)
[32].Taking into account all the features stated above, to go deeper and to
consider the stereochemistry of the cathinones, the enantiomeric ratio
quantification of the synthetic cathinones present in the “legal highs” previously
identified is crucial. Herein, firstly we described the analytical separation of the
enantiomers of nine synthetic cathinones (Fig. 1) present in 14 “legal highs”, by LC through different types of
CSPs, for determination of the enantiomeric ratios.
Fig. 1
Chemical structures of buphedrone, 3,4-dimethylmethcathinone
(3,4-DMMC), ethcathinone, flephedrone, methedrone, methylone,
4-methylethcathinone (4-MEC), 3,4- methylenedioxypyrovalerone (MDPV) and
pentedrone
Chemical structures of buphedrone, 3,4-dimethylmethcathinone
(3,4-DMMC), ethcathinone, flephedrone, methedrone, methylone,
4-methylethcathinone (4-MEC), 3,4- methylenedioxypyrovalerone (MDPV) and
pentedroneSecondly, considering the cytotoxic effects of MDPV [32], one of the most consumed cathinone
derivatives worldwide, we evaluated the in vitro hepatotoxicity of both enantiomers
of MDPV that were quantitatively separated with the semi-preparative tris-3,5-dimethylphenylcarbamate amylose CSP, under
normal phase elution conditions by multiple injections. Primary cultures of rat
hepatocytes were used for the in vitro cytotoxicity evaluation of each enantiomer of
MDPV, because acute or fulminant hepatic failure has been described in many cases of
intoxications following the consumption of cathinone derivatives [33, 34]. As far as we know, this is the first report dealing with in
vitro hepatotoxic effects of each MDPV enantiomer.
Materials and methods
Samples for analyses
Fourteen formulations of “legal highs” (Table 1) were acquired at “smart shops” (Porto, Portugal)
before the adoption of Portuguese Decree 54/2013, which prohibits the existence of
these stores and the marketing of these products [35]. All different samples were acquired in the form of powders,
except for Bliss sample A14, which was in the form of tablets. The chemical
identification and percentage of the synthetic derivatives present in “legal
highs” had been analyzed by GC–MS and NMR spectroscopy [32].
Table 1
Fourteen “legal high” products used in this study and their
chemical compositions
Reference standards also targeted: MDPV, 4-MEC, pentedrone,
methylone
aThe chemical compositions described in our
previous report [32]
bTablets
Fourteen “legal high” products used in this study and their
chemical compositionsReference standards also targeted: MDPV, 4-MEC, pentedrone,
methyloneaThe chemical compositions described in our
previous report [32]bTabletsThe synthetic standard cathinones methylone, pentedrone,
4-methylethcathinone (4-MEC), and MDPV were purchased over the Internet from
Sensearomatic (http://www.sensearomatic.com), and their purity was evaluated previously by mass spectrometry,
NMR, and elemental analysis [32].
Their purity was higher than 98 %.
Chemicals
Ethanol (EtOH), 2-propanol (2-PrOH), n-hexane (Hex), for LC purpose, were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Triethylamine (TEA), trifluoroacetic acid (TFA), sodium
chloride (NaCl), anhydrous sodium sulfate
(Na2SO4), sodium hydroxide (NaOH),
diethyl ether, chloroform, hydrochloric acid (HCl), and dimethyl sulfoxide (DMSO)
were of analytical grade being obtained also from Sigma-Aldrich.The Williams’ E medium, collagenase type IA from Clostridium histolyticum, gentamicin, dexamethasone,
bovinepancreas insulin solution, trypan blue solution, sodium pyruvate,
β-nicotinamide adenine dinucleotide reduced (β-NADH), and 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) were purchased from
Sigma-Aldrich; fetal bovine serum (FBS), fungizone, and a mixture of antibiotics
penicillin/streptomycin (10,000 U/mL/10,000 mg/mL) from GIBCO Invitrogen
(Barcelona, Spain); all other chemical reagents of analytical grade from Merck
(Darmstadt, Germany).
Equipment
The LC system used consisted of a JASCO model 880-PU pump (JASCO,
Tokyo, Japan), equipped with a Rheodyne model 7125 injector fitted with a 20 μL or
250 μL loop for analytical or semi-preparative resolution, respectively (Rheodyne,
Rohnert Park, CA, USA), a JASCO model 880-30 solvent mixer, a JASCO model
875-ultraviolet (UV) detector and a QR-2090 Plus chiral polarimeter detector
(JASCO). A DataApex CSW17 - chromatography station (DataApex, Prague, Czech
Republic) for Microsoft Windows 95 was employed. An LC system consisted of a
Finnigan Surveyor (Thermo Electron Corporation, Waltham, MA, USA) equipped with an
autosampler (AutoSampler Plus) and a diode array detector TSP UV6000LP (Thermo
Electron Corporation) was also employed. The treatment of the chromatographic data
was performed using the Xcalibur®2.0 SUR1 software
(Thermo Electron Corporation).Optical rotation values for each enantiomer of MDPV were determined
on a Polartronic Universal polarimeter with a sodium lamp (SCHMIDT + HAENSCH GmBH
& Co., Berlin, Germany), at 25º C (concentrations expressed in mg/mL; solvent:
EtOH). The volume of the measuring cell was 1 mL and the optical path was
10 cm.
Preparation of sample solutions
For analytical resolution, stock solutions of all 14 “legal high”
products purchased at smart shops, and the synthetic cathinones methylone,
pentedrone, 4-MEC, and MDPV were prepared by dissolution in EtOH at a
concentration of 1 mg/mL. Working solutions were further prepared by dilution of
the stock solutions in the same solvent to a concentration of 0.1 mg/mL and by
addition of 0.1 % TEA.The multi-milligram separation was optimized by adjusting the
sample size to scale-up of the analytical method. Solutions at 10 mg/mL of MDPV in
EtOH were also prepared for semi-preparative separation.The enantiomeric excess (ee) determination was carried out with
ethanolic solutions of each enantiomer of MDPV at a concentration of
0.1 mg/mL.
Chromatographic conditions
The analytical chromatographic columns used in this study were
Chiralpak® AS-H (15 cm × 4.6 mm ID, 5 µm particle
size) from Chiral Technologies Europe, Daicel Chemical Industries, Ltd., Osaka,
Japan, (S,S)-Whelk-O® 1 (25 cm, 4.6 mm ID, 5 μm
particle size) from Regis Technologies, Inc. (Morton Grove, IL, USA), l-Phenylglycine® column
(25 cm, 4.6 mm ID, 5 µm particle size) also from Regis Technologies, Inc.,
Chirobiotic® T (15 cm × 4.6 mm ID, 5 µm particle
size) from Astec (Whippany, NJ, USA), and the homemade polysaccharide based
columns [36, 37] consisted of amylosetris-3,5-dimethylphenylcarbamate (CSP1) and amylosetris-3,5-dimethoxyphenylcarbamate (CSP2), both coated
onto APS-Nucleosil (500 Å, 7 µm, 20 %, w/w; Phenomenex, Torrance, CA, USA) and
packed into a stainless-steel 15 cm × 4.6 mm ID size column.The chromatographic column for semi-preparative separation was
prepared as described elsewhere [37]
and is constituted by the CSP1 coated with APS-Nucleosil (500 Å, 7 µm, 20 %, w/w)
and packed into a stainless-steel 20 cm × 7.0 mm ID size column.All chromatographic analyses were performed at room temperature
under isocratic conditions. The chromatograms were monitored by UV detection at a
wavelength of 254 nm and polarimetric detection. The measurements were performed
under normal phase elution conditions. The mobile phase compositions were Hex and
EtOH or 2-PrOH with TEA as a modifier or with a mixture of TEA and TFA as
additives. The mobile phases were prepared in a volume/volume relation and
degassed in an ultrasonic bath for 15 min before use.For analytical chromatography the flow rate used was 0.5, 0.8 or
1 mL/min. The sample injections (20 µL) were carried out in duplicate. The dead
time (t0) was considered to be equal to the peak of the solvent
front and was taken from each run. The retention factor (k) was calculated by the equation The separation factor (α) was
calculated as α = (k2/k1). The resolution factor (Rs) was calculated using the
equation where tr1 and tr2
are the retention times of the first and second enantiomers, respectively, and
W10.5 and W20.5 are the corresponding peak width measured at half
height. The enantiomeric ratio (ER) was determined by the relative percentages of
the peak areas according to ER = E1/E2, where [E1] and [E2] are the peak area of
each enantiomer [38].
Multi-milligram enantioseparation of MDPV
Semi-preparative chromatographic separation of the enantiomers of
MDPV was first achieved through multiple injections fitted with a 250 µL loop,
using the mobile phase Hex/EtOH/TEA (97:3:0.1, v/v), under several flow rates and
λ = 254 nm. The collected fractions of each
enantiomer were injected (20 µL), in triplicate, on the analytical column under
the optimized chromatographic conditions to determine their ee. The ee was
determined by the relative percentages of the peak areas according to
where [E1] and [E2] are the peak area of each enantiomer
[38].All fractions of each enantiomer, obtained after multiple
injections of the working solutions totaling 100 mg amount of MDPV racemate, were
combined. The chromatographic fractions combined for each enantiomer were
evaporated under reduced pressure and the solid obtained was dissolved in 100 mL
of chloroform. The organic solution was washed with 1 M NaOH solution (5 × 25 mL)
and saturated NaCl solution (3 × 20 mL). The organic layer was dried with
anhydrous Na2SO4, filtered and
evaporated under reduced pressure. After elimination of TEA, both enantiomers were
precipitated in organic phase by acidification. Briefly, to each enantiomer a
small amount of diethyl ether was added, and then concentrated HCl solution was
added dropwise to form the precipitate, which was collected by filtration after
centrifugation (3000 rpm, 30 min). At the end of the procedure, 45.5 mg of the
first eluted MDPV enantiomer and 41.3 mg of its antipode could be obtained.
Cytotoxicity studies
Animals
Adult male Wistar rats (Charles-River Laboratories, Barcelona,
Spain) weighing 200–250 g were used to obtain primary hepatocytes. The animals
were conditioned in polyethylene cages in an environment with a temperature of
20 ± 2 °C, humidity of 40–60 % and a light/dark cycle at 12 h/12 h. The animals
were provided with free access to standard chow and water ad libitum. Surgical
procedures for isolation of the livers were performed under isoflurane
anesthesia at 10:00–11:00 a.m.
Isolation and culture of primary rat hepatocytes
Hepatocyte isolations were performed by the collagenase perfusion
method as described previously [39]. Briefly, the liver was digested by a two-step perfusion with
calcium-free Hanks’ salt solution followed by a solution containing collagenase.
The resulting hepatocyte suspension was purified by low speed centrifugation and
several washing procedures. The trypan blue exclusion test determined an initial
viability of isolated hepatocytes above 85 %.A suspension of 500,000 viable cells/mL in complete culture
medium (Williams’ E medium supplemented with 10 % FBS, 0.1 mg/mL streptomycin,
100 U/mL penicillin, 2 ng/mL insulin, 10 ng/mL gentamicin, and 5 nM
dexamethasone) was seeded in 96 wells plates (BD Biosciences, Oxford, UK). The
cells were incubated overnight for cell adhesion, at 37 °C with 95 %
O2/5 % CO2. The next day, the
cells were exposed to MDPV (racemate and each enantiomer), in a range of
0.2–1.6 mM in serum-free culture medium, for 24 and 48 h.
MTT reduction assay
The MTT reduction assay was performed as described previously
[40]. Briefly, cells were
incubated at 37 °C for 1.5 h with a solution of 500 g/mL MTT. The formazan
crystals, which were formed by mitochondrial succinate dehydrogenase, were
dissolved in 100 % DMSO, and detected at 550 nm in a 96-well plate reader
(PowerWaveX; Bio-Tek, Winooski, VT, USA). The data were normalized with the
positive and negative controls. For the positive control, untreated cells were
used, while 1 % Triton X-100 was used as negative control. Data were expressed
as mean ± standard deviation (SD) obtained from three independent experiments
performed in quadruplicate for each concentration.
Lactate dehydrogenase release assay
The lactate dehydrogenase (LDH) activity was determined by the
decrease in β-NADH absorbance during the reduction of pyruvate to lactate as
described previously [41] with some
modifications. After exposure of the cells to each enantiomer, the plates were
centrifuged at 250 g for 10 min. A 50-µL
volume each of the incubation medium from each well was transferred into new
plates (dilutions prepared in phosphate buffer: 50 mM
KH2PO4, pH 7.4) and 200 µL of
0.21 mM β-NADH (prepared in phosphate buffer) was added. After addition of 25 µL
of 22.7 mM sodium pyruvate, the oxidation of β-NADH to
β-NAD+ was monitored at 340 nm in a 96 well plate
reader. The data were normalized with positive and negative controls. For the
positive control, 1 % Triton X-100 was used. Untreated cells were used as
negative control. Data were reported as mean ± SD of three independent
experiments performed in quadruplicate.
Results and discussion
Enantiomeric resolution of cathinone derivatives present in “legal high”
products
Recently, LC using CSPs has emerged as one of the most helpful and
highly applicable methods for enantioresolution [42], determination of enantiomeric purity [43, 44] and preparation of enantiomerically pure compounds
[37]. Thus, a growing number of
CSPs have become available and are now routinely used [45]. Nowadays, polysaccharide-based, macrocyclic
antibiotics-based and Pirkle-type CSPs are pointed out as the most successful for
analytical and preparative separations of enantiomers [46]. In this work, these three different types
of CSPs were chosen to investigate the enantioresolution of nine cathinone
derivatives (Fig. 1) present in 14 “legal
high” products to determine further their enantiomeric ratios. The chemical
compositions of the “legal high” products were investigated and are listed in
Table 1 [32].Initially, only the samples with one synthetic cathinone in its
composition, being present in a percentage higher than 20 % (Blast A2, Rush A3,
Crabby A4, Cyclop A5, Bliss A6, Bliss A7, Blow A10, Blow A11, Kick A12, Kick A13,
and Bliss A14), and standards (methylone, pentedrone, 4-MEC, and MDPV) were
analyzed. Based on the literature, the commercial CSPs (S,S)-Whelk-O®1 [27] and Chiralpak®
AS-H [26] were chosen to start this
study.Regarding (S,S)-Whelk-O®1, a mobile phase
consisting of Hex/2-PrOH/TEA/TFA (90:10:0.05:0.05, v/v/v/v) was firstly used;
however, no enantiomeric separation was obtained. To overcome this situation, EtOH
was evaluated as organic modifier being an alternative to 2-PrOH. Thus, with the
mobile phase Hex/EtOH/TEA/TFA (90:10:0.05:0.05, v/v/v/v), a slight separation of
the enantiomers of methedrone present in sample Bliss A7 was observed. An increase
in the amount of Hex improved the enantioselectivity (α = 1.12) and resolution (Rs = 1.79) (Fig. 2).
Fig. 2
Liquid chromatogram of methedrone present in Bliss A7.
Conditions: column: (S,S)-Whelk-O® 1, mobile phase
n-hexane (Hex)/ethanol
(EtOH)/triethylamine (TEA)/trifluoroacetic acid (95:5:0.05:0.05, v/v/v/v),
flow rate 1 mL/min, ultraviolet (UV) detection 254 nm
Liquid chromatogram of methedrone present in Bliss A7.
Conditions: column: (S,S)-Whelk-O® 1, mobile phase
n-hexane (Hex)/ethanol
(EtOH)/triethylamine (TEA)/trifluoroacetic acid (95:5:0.05:0.05, v/v/v/v),
flow rate 1 mL/min, ultraviolet (UV) detection 254 nmConsidering that methedrone was the only synthetic cathinone
resolved on (S,S)-Whelk-O®1, the
Chiralpak® AS-H CSP was attempted to resolve the
enantiomers of the samples with one synthetic cathinone in its composition
(Table 1). Mobile phase Hex/2-PrOH/TEA
(97:3:0.1, v/v/v) with different flow rates were used namely 0.5, 0.8, and
1 mL/min to achieve this aim. Eight of nine synthetic cathinones were
enantioseparated with excellent enantioselectivity on
Chiralpak® AS-H CSP, with α and Rs ranging from 1.24
to 3.62 and from 1.24 to 10.52, respectively (Table 2). MDPV was the only synthetic cathinone not resolved on
Chiralpak® AS-H CSP. A set of chromatograms, at
optimized elution conditions, for synthetic cathinones, is depicted in
Fig. 3. Once the enantiomeric resolution
became possible for the cathinones present in the samples with only one cathinone
(except MDPV), all the remaining samples (Table 1) were injected under the same chromatographic conditions.
Table 2
Chromatographic data for the synthetic cathinones present in the
different samples using the Chiralpak® AS-H
chiral stationary phase
k retention factor, α separation factor, Rs resolution factor
Fig. 3
Liquid chromatograms of a
methedrone present in Bliss A7, b
methylone, c pentedrone, d flephedrone present in Blast A2, e 3,4-DMMC present in Cyclop A5, f 4-MEC, g and
h buphedrone present in Kick A13.
Conditions: column Chiralpak® AS-H, mobile
phase Hex/2-propanol (2-PrOH)/TEA (97:3:0.1, v/v/v), flow rate 1 mL/min
for (a, b), 0.8 mL/min for (c–f) or 0.5 mL/min for
(g, h), UV detection 254 nm (a–g) or polarimeter
(h)
Chromatographic data for the synthetic cathinones present in the
different samples using the Chiralpak® AS-H
chiral stationary phaseMobile phase conditions: n-hexane (Hex)/2-propanol (2-PrOH)/triethylamine (TEA)
(97:3:0.1,v/v/v), flow rate 0.5 mL/mink retention factor, α separation factor, Rs resolution factorLiquid chromatograms of a
methedrone present in Bliss A7, b
methylone, c pentedrone, d flephedrone present in Blast A2, e 3,4-DMMC present in Cyclop A5, f 4-MEC, g and
h buphedrone present in Kick A13.
Conditions: column Chiralpak® AS-H, mobile
phase Hex/2-propanol (2-PrOH)/TEA (97:3:0.1, v/v/v), flow rate 1 mL/min
for (a, b), 0.8 mL/min for (c–f) or 0.5 mL/min for
(g, h), UV detection 254 nm (a–g) or polarimeter
(h)It was possible to separate and identify both enantiomers of most
of cathinone derivatives present in all the “legal highs” with the
Chiralpak® AS-H CSP by comparing the enantiomeric
retention factors of the corresponding cathinone derivatives. Figure 4 shows an example of a representative chromatogram
obtained from the sample Bloom A1, which has in its composition the cathinone
derivatives methedrone, pentedrone, and ethcathinone. Although the enantiomeric
separation of the synthetic cathinones present in samples with two or more
cathinones was possible, in some of them the enantiomers of different cathinones
had similar retention times appearing with overlapping bands. For these cathinones
it was not possible to evaluate their ERs in the “legal high”.
Fig. 4
Liquid chromatogram of a pentedrone, b ethcathinone, and c
methedrone present in Bloom A1. Conditions: column
Chiralpak® AS-H, mobile phase Hex/2-PrOH/TEA
(97:3:0.1, v/v/v), flow rate 0.5 mL/min, UV detection 254 nm
Liquid chromatogram of a pentedrone, b ethcathinone, and c
methedrone present in Bloom A1. Conditions: column
Chiralpak® AS-H, mobile phase Hex/2-PrOH/TEA
(97:3:0.1, v/v/v), flow rate 0.5 mL/min, UV detection 254 nmTaking into account that MDPV was separated neither by (S,S)-Whelk-O® 1 nor by
Chiralpak® AS-H CSP, its enantioseparation was
attempted in four other CSPs, namely the Pirkle-type l-Phenylglycine®, the antibiotic based
Chirobiotic T®, and two homemade polysaccharide based
CSPs consisting of amylosetris-3,5-dimethylphenylcarbamate (CSP1) and amylosetris-3,5-dimethoxyphenylcarbamate (CSP2), both coated
onto APS-Nucleosil. Several mobile phases and flow rates were tried (data not
shown); however, enantioresolution was only achieved with polysaccharide based
CSPs. The best chromatographic results were achieved with CSP1 using the mobile
phase consisting of Hex/EtOH/TEA (97:3:0.1, v/v/v) and a flow rate of 0.5 mL/min,
being the elution time lower than 20 min (Fig. 5). The enantiomers of MDPV were resolved successfully with
excellent enantioselectivity and resolution, with α value of 1.70 and Rs of
3.11.
Fig. 5
Liquid chromatogram of MDPV. Conditions: column amylose
tris-3,5-dimethylphenylcarbamate
coated on APS-Nucleosil (CSP1), mobile phase Hex/EtOH/TEA (97:3:0.1,
v/v/v), flow rate 0.5 mL/min, UV detection 254 nm
Liquid chromatogram of MDPV. Conditions: column amylosetris-3,5-dimethylphenylcarbamate
coated on APS-Nucleosil (CSP1), mobile phase Hex/EtOH/TEA (97:3:0.1,
v/v/v), flow rate 0.5 mL/min, UV detection 254 nmThe good results on the enantioselectivity and resolutions allowed
the evaluation of the ERs of the synthetic cathinones present in the samples of
“legal highs”. The results are shown in Table 3. All synthetic cathinones were present mostly in an
enantiomeric proportion of 50:50 (ER approximately 1.0) with the exception of
4-MEC standard as well as in the “legal highs” Blow A10 and Blow A11, with the
(+)-enantiomer in higher amounts.
Table 3
Enantiomeric ratios (ERs) of synthetic cathinones present in the
samples of “legal highs”
Compound
Chromatographic conditions
Area % E1
Area % E2
ER
Blast A2 (flephedrone)
A
50.08 ± 0.02
49.92 ± 0.02
1.00
Standard pentedrone
A
51.38 ± 0.02
48.62 ± 0.02
1.06
Standard 4-MEC
A
63.53 ± 0.01
36.47 ± 0.01
1.74
Cyclop A5 (3,4-DMMC)
A
50.02 ± 0.02
49.98 ± 0.02
1.00
Bliss A7 (methedrone)
A
47.35 ± 0.02
52.65 ± 0.02
0.90
Kick A13 (buphedrone)
A
50.27 ± 0.01
49.73 ± 0.01
1.01
Standard methylone
A
50.04 ± 0.03
49.96 ± 0.03
1.00
Rush A3 (buphedrone)
A
50.20 ± 0.02
49.80 ± 0.02
1.01
Blow A11 (4-MEC)
A
62.94 ± 0.02
37.06 ± 0.02
1.70
Blow A10 (4-MEC)
A
61.90 ± 0.01
38.10 ± 0.01
1.62
Bliss A6 (methedrone)
A
49.88 ± 0.03
50.12 ± 0.03
1.00
Kick A12 (pentedrone)
A
54.06 ± 0.02
45.94 ± 0.02
1.18
Crabby A4 (3,4-DMMC)
A
49.21 ± 0.02
50.79 ± 0.02
0.97
Bloom A1 (ethcathinone)
A
50.14 ± 0.01
49.86 ± 0.01
1.01
Bloom A1 (pentedrone)
A
50.20 ± 0.02
49.80 ± 0.02
1.01
Bloom A1 (methedrone)
A
49.76 ± 0.02
50.24 ± 0.02
0.99
Bliss A14 (methylone)
A
49.96 ± 0.02
50.04 ± 0.02
1.00
Standard MDPV
B
49.97 ± 0.02
50.03 ± 0.02
1.00
Condition A column:
Chiralpak® AS-H, mobile phase Hex/2-PrOH/TEA
(97:3:0.1,v/v/v), flow rate 0.5 mL/min, ultraviolet (UV) detection
254 nm
Enantiomeric ratios (ERs) of synthetic cathinones present in the
samples of “legal highs”Condition A column:
Chiralpak® AS-H, mobile phase Hex/2-PrOH/TEA
(97:3:0.1,v/v/v), flow rate 0.5 mL/min, ultraviolet (UV) detection
254 nmCondition B column: CSP1 coated onto
APS-Nucleosil, mobile phase Hex/ethanol/TEA (97:3:0.1,v/v/v), flow
0.5 mL/min, UV detection 254 nm (n = 3)E1, E2
peak area of each enantiomerAdditionally, the elution order was determinated for the synthetic
cathinones 4-MEC, pentedrone, and buphedrone under the chromatographic conditions
present in Table 2 using a polarimeter
detector coupled to LC. The (+)-enantiomer was the first to elute in all cases.
Considering the low sensitivity of the available polarimeter it was not possible
to determine the elution order of the other cathinones.
Multi-milligram enantioresolution of MDPV
MDPV is one of the most consumed cathinone derivatives worldwide
and its hepatotoxicity has been demonstrated [32]. In the present study, multi-milligram resolution of both
enantiomers of MDPV was performed, using a semi-preparative CSP for further
cytotoxicity studies. This methodology has advantages over the indirect method,
because it does not require prior derivation. Based on the analytical
enantioseparation results (α = 1.70 and
Rs = 3.11), the CSP1 was chosen to scale-up to the preparative mode and isolate
both enantiomers of MDPV.The separation of MDPV enantiomers was optimized by adjusting the
amount of the sample from a scale-up of the analytical method. The optimized
mobile phase and the detector wavelength of the analytical system were the same,
as shown in Fig. 5. The column diameter
was increased from 4.6 to 7 mm, which corresponded to a scale factor of 3.
According to this factor, the flow rate was increased from 0.5 to 1.5 mL/min.
Considering that MDPV has a high solubility in EtOH, working solutions of 10 mg/mL
of MDPV were prepared. The loading effect in semi-preparative mode was tested by
injecting different volumes of the working solution. The volume of 100 µL was the
maximum throughput. Figure 6 shows the
chromatogram obtained by semi-preparative separation of MDPV.
Fig. 6
Liquid chromatogram with the semi-preparative separation column
for MDPV. Conditions: CSP1 semi-preparative column, mobile phase
Hex/EtOH/TEA (97:3:0.1, v/v/v), flow rate 1.5 mL/min, UV detection
254 nm
Liquid chromatogram with the semi-preparative separation column
for MDPV. Conditions: CSP1 semi-preparative column, mobile phase
Hex/EtOH/TEA (97:3:0.1, v/v/v), flow rate 1.5 mL/min, UV detection
254 nmMultiple injections of the working solutions totaling 100 mg of
MDPV resulted in 45.5 mg of the first eluted enantiomer and 41.3 mg of the second
eluted enantiomer, after elimination of the mobile phase additive (TEA) and
precipitation of each hydrochloride enantiomer of MDPV, with a recovery rate of
86.8 %. The MDPV was in racemate form (Table 3), meaning that 50 mg of each enantiomer was injected. Thus, the
recovery rate was 91.0 % for the enantiomer that eluted first and 82.6 % for the
later eluting enantiomer (Table 4). The
recovery rate would be higher if the procedures of TEA removal and the formation
of the hydrochloride were not necessary.
Table 4
Elution order, specific rotations, recoveries and enantiomeric
excess values for the resolved enantiomers of MDPV
aSpecific rotation in ethanol with a
concentration in mg/mL
b
ee enantiomeric excess determinated by
chiral liquid chromatography under the conditions described in
Fig. 7
Elution order, specific rotations, recoveries and enantiomeric
excess values for the resolved enantiomers of MDPVaSpecific rotation in ethanol with a
concentration in mg/mLb
ee enantiomeric excess determinated by
chiral liquid chromatography under the conditions described in
Fig. 7
Fig. 7
Liquid chromatograms for the enantiomeric excess of a
S-(−)-MDPV, b
R-(+)-MDPV, and c
R-(+)-MDPV after reinjection; CSP1
column; mobile phase Hex/EtOH/TEA (97:3:0.1, v/v/v/), flow rate 0.5 mL, UV
detection 254 nm
Determination of enantiomeric purity and specific rotation of MDPV
enantiomers
A solution of 10 mg/mL of each single enantiomer of MDPV was
prepared to measure its specific rotation in a polarimeter (Table 4). It was possible to verify that the levorotatory
one was the first eluted enantiomer and the dextrorotatory one was the second
eluted enantiomer. Moreover, based on a recent study that described the absolute
configuration of these enantiomers by X-ray crystallography [28], it can be inferred that in this study the
first enantiomer under the optimized chromatographic conditions was the S-(−)-MDPV and the second the enantiomer R-(+)-MDPV.The determination of ee for each enantiomer was performed using the
optimized chromatographic conditions associated to the best enantioselectivity.
Figure 7 shows the chromatograms
obtained during method development for measuring the ee values. The optimized
chiral LC conditions developed allowed the accurate determination of the ee of
each enantiomer of MDPV. Thus, the ee values for S-(−)-MDPV and R-(+)-MDPV were
higher than 99 and 94 %, respectively. To optimize the enantiomeric purity of
R-(+)-MDPV, a subsequent reinjection of
various fractions collected was performed, achieving an ee value higher than 99 %
(Fig. 7).Liquid chromatograms for the enantiomeric excess of a
S-(−)-MDPV, b
R-(+)-MDPV, and c
R-(+)-MDPV after reinjection; CSP1
column; mobile phase Hex/EtOH/TEA (97:3:0.1, v/v/v/), flow rate 0.5 mL, UV
detection 254 nmThe liver is the major target organ of xenobiotics; study of the
cytotoxicity of xenobiotics in isolated hepatocytes is a main focus [47]. Primary hepatocyte cultures remain the
standard model for metabolic studies and toxicity of xenobiotics [48]. Primary cultures of rat hepatocytes are a
good alternative to human cells because they have higher metabolic responses than
ordinary human cell lines and interindividual variability can be minimized by
selection of animals of the same gender and age and with similar diets
[49].Synthetic cathinone structure is related to amphetamines that are
known to be hepatotoxic [50].
Therefore, the studies in liver cells are of great importance to assess the toxic
effects of xenobiotics. Our group has recently demonstrated the in vitro
hepatotoxic potential of four of the most prevalent cathinone derivatives, namely
methylone, MDPV, 4-MEC, and pentedrone [32].In this study, a chiral resolution method for the isolation of
enantiomers of MDPV was developed to obtain adequate quantities to test the
toxicity of MDPV enantiomers in primary rat hepatocytes and to verify the
enantioselectivity. We demonstrated that MDPV enantiomers, as well as the racemic
product, induced cell death in a concentration-dependent manner, as shown by the
decline in MTT reduction and increase in LDH leakage (Figs. 8, 9,
respectively). Both racemic MDPV and each of its enantiomers were significantly
hepatotoxic at concentrations as low as 0.2 mM at 48 h (p < 0.0001 vs. control), as shown in Fig. 8. The reason why we additionally performed the LDH
leakage assays, under the same experimental conditions, was to circumvent the fact
that MDPV, as a ketone, could interfere with redox-based tests like the MTT assays
[51]. The obtained results shown in
Fig. 9, corroborated the results from
the MTT assays, showing cell death in similar magnitude and significance.
Fig. 8
Reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) by primary rat
hepatocytes exposed to racemic MDPV hydrochloride or individual
enantiomers (0.2–1.6 mM) for 24 and 48 h. Data were obtained from three
independent experiments, run in quadruplicate. ***p < 0.001, ****p < 0.0001 vs. control. ##
p < 0.01 vs. racemic
MDPV
Fig. 9
Lactate dehydrogenase (LDH) release by primary rat hepatocytes
exposed to racemic MDPV hydrochloride or individual enantiomers
(0.2–1.6 mM) for 24 and 48 h. Data were obtained from three independent
experiments, run in quadruplicate. *p < 0.05,**p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control. ##
p < 0.01,
###
p < 0.001 vs. racemic
MDPV
Reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) by primary rat
hepatocytes exposed to racemic MDPV hydrochloride or individual
enantiomers (0.2–1.6 mM) for 24 and 48 h. Data were obtained from three
independent experiments, run in quadruplicate. ***p < 0.001, ****p < 0.0001 vs. control. ##
p < 0.01 vs. racemic
MDPVLactate dehydrogenase (LDH) release by primary rat hepatocytes
exposed to racemic MDPV hydrochloride or individual enantiomers
(0.2–1.6 mM) for 24 and 48 h. Data were obtained from three independent
experiments, run in quadruplicate. *p < 0.05,**p < 0.01, ***p < 0.001, ****p < 0.0001 vs. control. ##
p < 0.01,
###
p < 0.001 vs. racemic
MDPVIt should be emphasized that no marked differences were found
between the effects of racemic MDPV and each of its enantiomers
(Figs. 8, 9), with the exception of some particular significant
differences, namely 0.4 mM R-(+)-MDPV in the
MTT reduction assay at 48 h (p < 0.01 vs.
racemic MDPV), 1.6 mM S-(−)-MDPV in the LDH
release assay at 24 h (p < 0.001 vs. racemic
MDPV) and 0.8 mM R-(+)-MDPV at 48 h in the LDH
release assay (p < 0.01 vs. racemic MDPV).
With these results we can conclude that there is no MDPV enantioselectivity for
its toxicity in this cellular in vitro model.
Conclusions
LC method using polysaccharide-based CSPs under normal phase elution
conditions was effective for the enantiomeric separation of synthetic cathinones.
All the synthetic cathinones were efficiently enantioseparated with α and Rs ranging
from 1.24 to 3.62 and from 1.24 to 10.52, respectively. The polysaccharide-based
Chiralpak® AS-H CSP was successfully employed for the
enantioresolution of this class of compounds; however, the separation of the
enantiomers of the synthetic cathinone MDPV was only possible with the
polysaccharide-based CSP consisting of amylosetris-3,5-dimethylphenylcarbamate coated onto APS-Nucleosil. All the
synthetic cathinones, except 4-MEC, are present in the “legal highs” as racemic
mixture (ER approximately 1.0).The optimized analytical LC conditions were successfully scale-up for
the milligram enantioresolution of MDPV. In fact, the enantiomers of MDPV were
isolated, for the first time, by semi-preparative LC using amylosetris-3,5-dimethylphenylcarbamate coated onto
APS-Nucleosil. The enantiomers were achieved with a high degree of enantiomeric
purity (ee > 99 %) with the levorotatory form as the first enantiomer to be
eluted. It was also possible to verify that every form of MDPV was hepatotoxic at a
concentrations as low as 0.2 mM at 48 h (p < 0.0001 vs. control), without any enantioselectivity, according to
the MTT reduction assays performed in primary cultures of rat hepatocytes. The
results by LDH leakage assays essentially gave the same results. The strategy
applied in this study can be applied to other cathinone derivatives to investigate
enantioselectivity on their toxicity.
Authors: Maria Emília Sousa; Maria Elizabeth Tiritan; Kátia Roberta Anacleto Belaz; Madalena Pedro; Maria São José Nascimento; Quezia Bezerra Cass; Madalena Maria Magalhães Pinto Journal: J Chromatogr A Date: 2006-01-30 Impact factor: 4.759
Authors: Bjørnar den Hollander; Mira Sundström; Anna Pelander; Ilkka Ojanperä; Eero Mervaala; Esa Risto Korpi; Esko Kankuri Journal: Toxicol Sci Date: 2014-06-09 Impact factor: 4.849
Authors: Ana Sofia Almeida; Bárbara Silva; Paula Guedes de Pinho; Fernando Remião; Carla Fernandes Journal: Molecules Date: 2022-03-22 Impact factor: 4.411
Authors: Bárbara Silva; Joana Saraiva Rodrigues; Ana Sofia Almeida; Ana Rita Lima; Carla Fernandes; Paula Guedes de Pinho; Joana Paiva Miranda; Fernando Remião Journal: Pharmaceuticals (Basel) Date: 2022-03-17